APA
Bernardino J. I., Mocroft A., Wallet C., de Wit S., Katlama C., Reiss P., Mallon P. W., Richert L., Molina J., Knobel H., Morlat P., Babiker A., Pozniac A., Raffi F. & Arribas J. R. (20190923). Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial. : PloS one.
Chicago
Bernardino Jose I, Mocroft Amanda, Wallet Cedrick, de Wit Stéphane, Katlama Christine, Reiss Peter, Mallon Patrick W, Richert Laura, Molina Jean-Michel, Knobel Hernando, Morlat Philippe, Babiker Abdel, Pozniac Anton, Raffi Francois and Arribas Jose R. 20190923. Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial. : PloS one.
Harvard
Bernardino J. I., Mocroft A., Wallet C., de Wit S., Katlama C., Reiss P., Mallon P. W., Richert L., Molina J., Knobel H., Morlat P., Babiker A., Pozniac A., Raffi F. and Arribas J. R. (20190923). Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial. : PloS one.
MLA
Bernardino Jose I, Mocroft Amanda, Wallet Cedrick, de Wit Stéphane, Katlama Christine, Reiss Peter, Mallon Patrick W, Richert Laura, Molina Jean-Michel, Knobel Hernando, Morlat Philippe, Babiker Abdel, Pozniac Anton, Raffi Francois and Arribas Jose R. Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial. : PloS one. 20190923.